{"name":"Osprey Medical, Inc","slug":"osprey-medical-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Timentin","genericName":"Timentin","slug":"timentin","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Timentin","genericName":"Timentin","slug":"timentin","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQLW0xNVprUVpHQzVHWDVJMDRTR1A0SmtzenpVT1lGS2tXVGlHV2VEYlp5Sy1vdmZkOEw4WFh1LTdXb2s3NHFYcVVxTkdsQ3p2cVlLMUNYdGhDMERwSlJnOU5tUDdvZWJCcUI4WG1qcVJtaEF1RVNPM21jUGx6eUN5UUlFU2NpTDloZnAzdG9haXFXSEE?oc=5","date":"2025-05-29","type":"trial","source":"Medical Product Outsourcing","summary":"LivaNova Announces 12-month Data from OSPREY Study - Medical Product Outsourcing","headline":"LivaNova Announces 12-month Data from OSPREY Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxNc1ljX0dPWUdLbVpCSG1lUm9FTmFFNmh1YmVLaGVpU0M4dWlxR1RIQ0hZdlllSUJuZDBsRTVwSHEySW5wVHNYbkNibXlxUGh0c3pFdm9PX3NBVUNPZ0Iwd0ZaV01sNWZnYUZFOEFYOEhVdmZIeFNfUjYzSVpxRFdNWWdFdlB6VnJ3NDVvWXdYZHFHbVBHWHp5LS05VXR6eXNLVjhnM29jc2d5cmhDRzhDdFU2Z0VnZDU2?oc=5","date":"2018-10-11","type":"pipeline","source":"Healio","summary":"Antithrombotic therapy after PCI in AF requires careful consideration - Healio","headline":"Antithrombotic therapy after PCI in AF requires careful consideration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPNWR5eDZZNVJUWDhhenRTV21pNWlfeHlOS2pTOVNDTWNnU3BjZG9lVDJKV0RjOElVTFJCdXFEY2VwOGd1WHBfQkt1REVKbHVuQTBFNXZoQy00UUhKdTMwaGJ4ZXlXNmVoOVlkX0J4UC0tbGJrLWlSRFFEUVhwSndJVmFSZElBcTZoY3ljWEdobzZiYUM4V2JUTS1yVVo0WUI3MFhOTWI3OTVlRmNQdkpUaUVMdTQ?oc=5","date":"2016-08-05","type":"pipeline","source":"dicardiology.com","summary":"Osprey Receives $28 Million in Funding for its Cath Lab Contrast Reduction Technology - dicardiology.com","headline":"Osprey Receives $28 Million in Funding for its Cath Lab Contrast Reduction Technology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxORU9PTVptdWhMTmtLU2FzSzZFQ1hWamEwMDViXzdzSUJrb2FJdVQ1T1RYbXZZLTVRcWtzaGJiVEg4QjlXUWNvOWRBbV93aGRmekt3T3JLZ2gwajc5dFY5S0xlLUxsWXFLaDJVM29uS3lJbWVxa3ZFSUlvTFlmVTFxNXhtOFAyWEZNU2NUa2N4MFBPRHZmUmdjVExGdm8waFdSVkJfSFJZZFp3LWZQaVE?oc=5","date":"2015-12-16","type":"deal","source":"dicardiology.com","summary":"Lantheus Announces Partnership for Distribution of Definity Echo Contrast in China - dicardiology.com","headline":"Lantheus Announces Partnership for Distribution of Definity Echo Contrast in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOSHcyN2tUanY2aEM1QXg2Yk9tSGJlMjhRSkhwcVI5ci1RUmlBeGlhbFdzM0FUVEtySGtJMVd0bUJiM2NOd2p6SzVZQktQaFFzM25sa3dVUzZJWDB4dTI0N3NSaEFjVmpmdW5vTFVJVWRpWnZRVmZrMFdCclFzQUFHZDU0bmJtOVhnTmY5VDVRU2toVmNkT3lGSUM0bjZubGQ3MzdZa2ltdkNDZkZCSmNrR1NMRVFaaUZyYnhxbmhMWVU0VTAw?oc=5","date":"2015-04-20","type":"pipeline","source":"AFR","summary":"Brandon Capital raises $200m from four industry funds for medical VC - AFR","headline":"Brandon Capital raises $200m from four industry funds for medical VC","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}